Financial results - MIHMED PHARMA LINE SRL

Financial Summary - Mihmed Pharma Line Srl
Unique identification code: 30592630
Registration number: J03/1168/2012
Nace: 4646
Sales - Ron
-
Net Profit - Ron
Employees
Open Account
Company Mihmed Pharma Line Srl with Fiscal Code 30592630 recorded a turnover of 2024 of - , with a net profit of - and having an average number of employees of - . The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Mihmed Pharma Line Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 17.046 3.251 36.941 37.862 28.538 0 1.294 65 0 0
Total Income - EUR 17.046 3.251 36.941 38.079 28.539 1 6.025 65 0 0
Total Expenses - EUR 10.535 5.294 21.195 16.612 22.373 5.519 6.662 214 110 0
Gross Profit/Loss - EUR 6.511 -2.043 15.747 21.467 6.166 -5.518 -638 -149 -110 0
Net Profit/Loss - EUR 6.000 -2.146 14.638 20.331 5.309 -5.518 -819 -151 -110 0
Employees 0 0 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Mihmed Pharma Line Srl

Rating financiar

Financial Rating -
MIHMED PHARMA LINE SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Mihmed Pharma Line Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Mihmed Pharma Line Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Mihmed Pharma Line Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Mihmed Pharma Line Srl - CUI 30592630

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 65 13.724 11.093 8.484 6.004 276 111 0 0
Current Assets 35.749 27.774 29.067 50.740 67.264 48.901 52.553 46.656 46.515 46.255
Inventories 1.903 1.281 5.144 2.454 2.373 2.328 1.464 1.421 1.416 1.408
Receivables 1.359 312 4.746 316 11.864 161 121 187 187 186
Cash 32.488 26.181 19.177 47.970 53.028 46.412 50.967 45.048 44.912 44.661
Shareholders Funds 30.294 27.839 42.007 61.567 65.684 53.494 46.435 46.428 46.177 42.300
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 6.422 0 795 267 10.081 1.412 6.394 338 337 3.954
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 46.255 euro in 2024 which includes Inventories of 1.408 euro, Receivables of 186 euro and cash availability of 44.661 euro.
The company's Equity was valued at 42.300 euro, while total Liabilities amounted to 3.954 euro. Equity decreased by -3.619 euro, from 46.177 euro in 2023, to 42.300 in 2024.

Risk Reports Prices

Reviews - Mihmed Pharma Line Srl

Comments - Mihmed Pharma Line Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.